Barely Significant
← all phrases

“an increasing trend”

63,972 sentences · 63,972 papers · 107,686 search hits before verification · confirmed specimen

Sighted at

p<0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

an increasing trendP < 0.0010.0× alphagold
a decreasing trendP < 0.010.2× alphagold
Results The serum levels of 25(OH)D, 25(OH)D3, and F25(OH)D showed a decreasing trend ( z = −2.781–−3.996, P < 0.01) in RA patients with CKD progression from mild to severe, while C3-epi-25(OH)D3 showed an increasing trend ( z = 6.741, P < 0.001) and 25(OH)D2 showed no significant difference among the groups ( z = 0.976, P = 0.329).
an increasing trendp < .0010.0× alphagold
Regarding lithium dosage, with a dosage of < 600 mg as the reference group, each of the other two subgroups (i.e., 601–1200 mg and > 1200 mg) demonstrated no significant difference in leukocytosis development; however, an increasing trend of leukocytosis incidence with an increase in lithium daily dosage was observed ( p < .001; Fig. 1 D).
an increasing trendP < 0.0010.0× alphagold
CRF developmental trajectories showed an upward trend over five surveys (slope = 0.649, P < 0.001); PD showed a significant weakening trend (slope = − 0.583, P < 0.001); SD showed an increasing trend (slope = 0.345, P < 0.001), and QoL showed a statistically significant weakening trend (slope = − 0.373, P < 0.001).
an increasing trendP < 0.0010.0× alphagold
Group A was defined as the group of patients who had a mild level of fatigue at baseline, with their fatigue level demonstrating an increasing trend during the treatment period but consistently remaining at a mild level ( I = 1.111, P < 0.001; S = 0.439, P < 0.001).
an increasing trendP < 0.0010.0× alphagold
67 In the Copenhagen Male Study, for example, which was an 8-year follow-up of 2906 men free of CAD, an increasing trend ( P < 0.001) between triglyceride concentration and CAD events was shown to be independent of other risk factors including HDL cholesterol concentrations. 68 Other data from the Atherosclerosis Risk in Communities Study (ARIC), which was a 10-year follow-up of 12,339 middle-aged North American subj
an increasing trendP < 0.0010.0× alphagold
Similarly, there was an increasing trend in the total PQ base dosage administered (242.6 ± 79.7 vs. 265.7 ± 92.3 mg, P < 0.001), despite no significant differences in total weight-based PQ base dosage administered (3.38 ± 1.1 vs. 3.64 ± 1.3 mg/kg, P = 0.256) or the proportion of patients in the underdosing group (< 3.5 mg/kg; 296 [73.6%] vs. 167 [68.2%], P = 0.135] between the two periods.